Anti-LSP1 antibody
US10968281B2 · kind B2 · utility
0Cited by
1References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 13, 2017 |
| Grant date | Apr 6, 2021 |
| Priority date | — |
| Expiry date | Oct 13, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/7095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a new anti-LSP1 (Leukocyte specific protein 1) antibody. This new antibody allows the specific staining of inflammatory dendritic cells and can be used in diagnosis methods or as a medicament when conjugated to a drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.